[1]Wells RG.Cellular sources of extracellular matrix in hepatic fibrosis[J].Clin Liver Dis, 2008, 12 (4) :759-768.
|
[2]刘毅, 刘立新, 郭晓红, 等.IGFBP-rP1对肝星状细胞活化及核因子-κB活性的影响[J].中国病理生理杂志, 2008, 24 (9) :1789-1793.
|
[3] 张骞骞, 刘立新, 郭晓红, 等.胰岛素样生长因子结合蛋白7在活化肝星状细胞促肝纤维化中的作用[J].中华消化外科杂志, 2009, 8 (6) :457-459.
|
[4]Corey DR.Chemical modification:the key to clinical application of RNA interference?[J].J Clin Invest, 2007, 117 (12) :3615-3622.
|
[5]Kim D, Rossi J.RNAi mechanisms and applications[J].Biotechniques, 2008, 44 (5) :613-616.
|
[6]Tacke F, Weiskirchen R.Liver fibrosis-Pathogenesis and novel therapeutic approaches[J].Internist (Berl) , 2010, 51 (1) :21-29.
|
[7]Friedman SL.Mechanisms of hepatic fibrogenesis[J].Gastroenterology, 2008, 134 (6) :1655-1669.
|
[8]Atzori L, Poli G, Perra A.Hepatic stellate cell:A star cell in the liver[J].Int J Biochem Cell Biol, 2009, 41 (8-9) :1639-1642.
|